Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Arrowhead Research (ARWR) PT Raised to $24.50 at Chardan Capital Markets
-
Chardan Capital Markets Reiterates Buy on 22nd Century Group (XXII) Following Study
-
Chardan Capital Markets Starts iRhythm Technologies (IRTC) at Buy
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $21 at Chardan Capital Markets
-
HealthEquity, Inc (HQY) PT Raised to $118 at Chardan Capital Markets
-
Jerrick Media Holdings, Inc. Accomplished Converting Over $12,000,000 of Securities In Addition to Placing $3,000,000 of Common Stock and Warrants as Part of an Upround Private Placement
-
UPDATE: Chardan Capital Markets Starts R1 RCM Inc (RCM) at Buy
-
Chardan Capital Markets Starts Tocagen Inc. (TOCA) at Buy
-
Megalith Financial Acquisition Corp. Announces Closing of $150,000,000 Initial Public Offering
-
Megalith Financial Acquisition Corp. Announces Closing of $150,000,000 Initial Public Offering
-
Chardan Serves as Sole Book-Runner for Megalith Financial Acquisition Corp.
-
Megalith Financial Acquisition Corp. (MFAC) Prices 15M Unit IPO at $10/Unit
-
Megalith Financial Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Megalith Financial Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Chardan Capital Markets Starts MeiraGTx Holdings plc (MGTX) at Buy
-
Atlantic Acquisition Corp. Announces Completion of Merger with HF Group Holding Corp.
-
Genius Brands International Raises $4.5 Million in Funding Round Led by Robert Wolf's 32 Ventures
-
Safe-T Announces Closing of $7.335 Million Underwritten Public Offering
-
Chardan Capital Markets acts as Sole Placement Agent in $10 Million Securities Purchase
-
Safe-T Group Ltd. (SFET) IPO Opens 16% Lower
-
Pre-Open Movers 08/17: (IZEA) (ZOES) (JWN) Higher; (ZN) (VNET) (DF) Lower (more...)
-
Chardan Capital Markets Downgrades Amicus Therapeutics (FOLD) to Neutral
-
Safe-T Group Ltd. (SFET) Prices 510.4K ADS Offering at $14.35/ADS
-
Safe-T Announces Pricing of $7.335 Million Underwritten Public Offering
-
Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
-
Social Reality (SRAX) PT Doubled to $10 at Chardan Capital Markets
-
Chardan Capital Markets Starts eHealth (EHTH) at Buy
-
Emergent BioSolutions (EBS) PT Raised to $60 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades Sunworks (SUNW) to Neutral
-
Homology Medicines Reports Second Quarter 2018 Financial Results
-
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Chardan Capital Markets Downgrades Globalstar (GSAT) to Neutral
-
Regenxbio Inc. (RGNX) PT Lowered to $127.50 at Chardan Capital Markets; Sees Low Bar in Wet AMD
-
Model N, Inc. (MODN) PT Raised to $24 at Chardan Capital Markets
-
Arrowhead Research (ARWR) PT Raised to $17.50 at Chardan Capital Markets
-
SRAX Closes Sale of SRAXmd and Receives $33.5 Million in Cash Plus Additional Consideration
-
Greenland Acquisition Corporation Announces that Ordinary Shares, Rights, and Warrants to Commence Separate Trading on or about August 8, 2018
-
Greenland Acquisition Corporation Announces that Ordinary Shares, Rights, and Warrants to Commence Separate Trading on or about August 8, 2018
-
Tottenham Acquisition I Limited Announces Closing of Initial Public Offering
-
Benefitfocus (BNFT) PT Raised to $36 at Chardan Capital Markets
-
Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets
-
Tottenham Acquisition I Limited (TOTAU) Prices 4M Unit IPO at $10/Unit
-
Tottenham Acquisition I Limited Announces Pricing of $40 Million Initial Public Offering
-
Chardan Capital Markets Downgrades Castlight Health Inc. (CSLT) to Neutral
-
Chardan Capital Markets Starts ADMA Biologics (ADMA) at Buy, Is Positive on Turnaround Story
-
Social Reality (SRAX) Reports Agreement to Sell SRAXmd for Up to $52.5M
-
SRAX Agrees to Sell SRAXmd for Up to $52.5 Million
-
Greenland Acquisition Corporation Announces Closing of $44 Million Initial Public Offering
-
Greenland Acquisition Corporation Announces Closing of $44 Million Initial Public Offering
-
OncoCyte (OCX) Announces At-Market $3.59 Million Offering of Common Stock, Warrants

